✦ LIBER ✦

T.P.31 Biochemical and clinical variability of Becker muscular dystrophy: Predicting optimal target exons for exon skipping therapy in Duchenne muscular dystrophy

✍ Scribed by Anthony, K.; Arechavala-Gomeza, V.; Ricotti, V.; Torelli, S.; Feng, L.; Tasca, G.; Guglieri, M.; Barresi, R.; Armaroli, A.; Ferlini, A.; Bushby, K.; Straub, V.; Ricci, E.; Sewry, C.; Morgan, J.; Muntoni, F.

Book ID: 119333822
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 47 KB
Volume: 22
Category: Article
ISSN: 0960-8966
DOI: 10.1016/j.nmd.2012.06.196

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

T.P.2.04 Optimization of antisense-media

T.P.2.04 Optimization of antisense-mediated exon skipping in mouse models for Duchenne muscular dystrophy

✍ A. Aartsma-Rus; H.A. Heemskerk; C.L. de Winter; M. van Putten; S. De Kimpe; J.C. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 49 KB

T.P.1.04 Dual exon skipping in myostatin

T.P.1.04 Dual exon skipping in myostatin and dystrophin as a potential therapy for Duchenne muscular dystrophy

✍ D.U. Kemaladewi; W.M.H. Hoogaars; S.H. van Heiningen; J.C.T. van Deutekom; J.T. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 39 KB

T.P.1 03 Gene expression profiling to mo

T.P.1 03 Gene expression profiling to monitor therapeutic and adverse effects of antisense-induced exon skipping for Duchenne muscular dystrophy

✍ P.A.C. ’t Hoen; C.G.C. van der Wees; A. Aartsma-Rus; R. Turk; A. Goyenvalle; O. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 46 KB

T.P.1.02 Importance of checking exon ski

T.P.1.02 Importance of checking exon skipping events prior to clinical trials using systemically delivered antisense morpholino in Duchenne muscular dystrophy patients

✍ S. Nakono; S. Ozasa; H. Kosuge; K. Nomura; I. Fujii; K. Ito; M. Matsukura; S. Ki 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 39 KB